OUR CHALLENGE
Sustained delivery of Active Pharmaceutical Ingredients (APIs)
APPLICATION + API


Treatment optimization -> Bioavailability
Improves the integration of treatment into patients’ daily lives -> therapeutic adherence
THE NEED
CURRENT SOLUTION : Synthetic polymers/plastics
• Release with burst effect
• Incompatible with the loading of many APIs
Peptides & therapeutic proteins, small hydrophilic molecules

OUR SOLUTION
Native albumin-based materials for sustained drug delivery
Injectable microparticles
Native human albumin

Most abundant plasma protein
• Biocompatible, biodegradable, non-immunogenic
• Available raw materials (GMP grade)
• Natural carrier protein (established therapeutic use for drug delivery)
Non-denaturing process for the production of protein-based materials
Patent : European patent (2019), PCT extension (2020), National phases Expertise
Material Ι Process Ι Application
Exclusive licensing agreement concluded with Conectus 2024
OUR TECHNOLOGY
Non-denaturing process for the preparation of protein-based materials



Albumin + Salt
Evaporation 37°C
Washing (water)
100% Native Albumin
EXPERTISE
Formulation development Drug encapsulation





MEMBRANES
COMPACT MATERIALS
SPONGES
EXTRUDABLE MATERIALS
MICROPARTICLES